Nguyen VAN Trang1, Kiesha Prem2, Zheng Quan Toh3,4, Bui Thi Viet Ha5, Pham Thi Ngoc Lan6, Hau Phuc Tran7, Quang Duy Pham7, Nghia VAN Khuu7, Mark Jit2,8,9, Dung Thi Luu10, LE Thi Khanh Ly1, VAN Cao7, Tam-Duong LE-Ha7, Kathryn Bright3, Suzanne M Garland3,11,12, Dang Duc Anh13, Kim Mulholland14,3,4. 1. National Institute of Hygiene and Epidemiology, Hanoi, Vietnam. 2. Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, U.K. 3. Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia. 4. Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia. 5. Department of Microbiology, University of Science, Vietnam National University, Hanoi, Vietnam. 6. Department of Natural Science, Vietnam National University of Hue, Hue, Vietnam. 7. Pasteur Institute of Ho Chi Minh City, Ho Chi Minh City, Vietnam. 8. School of Public Health, University of Hong Kong, Hong Kong, SAR, P.R. China. 9. Public Health England, Modelling and Economics Unit, London, U.K. 10. National Institute for Control of Vaccines and Biologicals, Hanoi, Vietnam. 11. Centre for Women's Infectious Diseases, The Royal Women's Hospital, Parkville, Victoria, Australia. 12. Department of Obstetrics and Gynecology, The University of Melbourne, Parkville, Victoria, Australia. 13. National Institute of Hygiene and Epidemiology, Hanoi, Vietnam; dda@nihe.org.vn. 14. Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, U.K.; kim.mulholland@mcri.edu.au.
Abstract
BACKGROUND/AIM: Cervical cancer is the second most common malignancy among women in Vietnam, but the country is yet to introduce a national human papillomavirus (HPV) vaccine programme targeted at adolescents. We determined HPV prevalence and HPV vaccine knowledge among female university students in Vietnam. PATIENTS AND METHODS: We surveyed and screened 1,491 female university students in Hanoi, Hue, and Ho Chi Minh City for their sexual behaviours, HPV knowledge and low- and high-risk HPV infection. RESULTS: The prevalence of any HPV infection and any high-risk HPV infection were 4.2% (95%CI=3.3%-5.4%) and 3.4% (95%CI=2.5%-4.4%), respectively. Being sexually active [adjusted prevalence ratio (aPR): 6.22; 95%CI=3.4-11.37] and having ever been pregnant (aPR: 4.82; 95%CI=1.93-12.04) were positively associated with high-risk HPV infection. Whilst 60% of participants had heard of HPV vaccine, only 4.6% had received the vaccine. CONCLUSION: The low HPV prevalence found in university students in Vietnam indicates that they can benefit from HPV vaccination, along with a well-designed HPV health promotion programme.
BACKGROUND/AIM: Cervical cancer is the second most common malignancy among women in Vietnam, but the country is yet to introduce a national human papillomavirus (HPV) vaccine programme targeted at adolescents. We determined HPV prevalence and HPV vaccine knowledge among female university students in Vietnam. PATIENTS AND METHODS: We surveyed and screened 1,491 female university students in Hanoi, Hue, and Ho Chi Minh City for their sexual behaviours, HPV knowledge and low- and high-risk HPV infection. RESULTS: The prevalence of any HPV infection and any high-risk HPV infection were 4.2% (95%CI=3.3%-5.4%) and 3.4% (95%CI=2.5%-4.4%), respectively. Being sexually active [adjusted prevalence ratio (aPR): 6.22; 95%CI=3.4-11.37] and having ever been pregnant (aPR: 4.82; 95%CI=1.93-12.04) were positively associated with high-risk HPV infection. Whilst 60% of participants had heard of HPV vaccine, only 4.6% had received the vaccine. CONCLUSION: The low HPV prevalence found in university students in Vietnam indicates that they can benefit from HPV vaccination, along with a well-designed HPV health promotion programme.
Authors: Akiko Kamimura; Ha N Trinh; Shannon Weaver; Alla Chernenko; Lindsey Wright; Mary Stoddard; Maziar M Nourian; Hanh Nguyen Journal: J Infect Public Health Date: 2017-06-28 Impact factor: 3.718
Authors: Silvia Franceschi; Rolando Herrero; Gary M Clifford; Peter J F Snijders; Annie Arslan; Pham Thi Hoang Anh; F Xavier Bosch; Catterina Ferreccio; Nguyen Trong Hieu; Eduardo Lazcano-Ponce; Elena Matos; Monica Molano; You-Lin Qiao; Raj Rajkumar; Guglielmo Ronco; Silvia de Sanjosé; Hai-Rim Shin; Sukhon Sukvirach; Jaiye O Thomas; Chris J L M Meijer; Nubia Muñoz Journal: Int J Cancer Date: 2006-12-01 Impact factor: 7.396
Authors: G M Clifford; S Gallus; R Herrero; N Muñoz; P J F Snijders; S Vaccarella; P T H Anh; C Ferreccio; N T Hieu; E Matos; M Molano; R Rajkumar; G Ronco; S de Sanjosé; H R Shin; S Sukvirach; J O Thomas; S Tunsakul; C J L M Meijer; S Franceschi Journal: Lancet Date: 2005 Sep 17-23 Impact factor: 79.321
Authors: Eileen F Dunne; Elizabeth R Unger; Maya Sternberg; Geraldine McQuillan; David C Swan; Sonya S Patel; Lauri E Markowitz Journal: JAMA Date: 2007-02-28 Impact factor: 56.272
Authors: A Hildesheim; M H Schiffman; P E Gravitt; A G Glass; C E Greer; T Zhang; D R Scott; B B Rush; P Lawler; M E Sherman Journal: J Infect Dis Date: 1994-02 Impact factor: 5.226
Authors: Harriet Richardson; Gail Kelsall; Pierre Tellier; Hélène Voyer; Michal Abrahamowicz; Alex Ferenczy; François Coutlée; Eduardo L Franco Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-06 Impact factor: 4.254
Authors: Rodrigo Covre Vieira; Jeniffer do Socorro Valente Monteiro; Estéfane Primo Manso; Maria Renata Mendonça Dos Santos; Mihoko Yamamoto Tsutsumi; Edna Aoba Yassui Ishikawa; Stephen Francis Ferrari; Karla Valéria Batista Lima; Maísa Silva de Sousa Journal: Infect Agent Cancer Date: 2015-07-22 Impact factor: 2.965
Authors: Bach Xuan Tran; Phung Tat Quoc Than; Tien Thuy Ngoc Doan; Huong Lan Thi Nguyen; Hue Thi Mai; Trang Huyen Thi Nguyen; Huong Thi Le; Carl A Latkin; Melvyn Wb Zhang; Roger Cm Ho Journal: Patient Prefer Adherence Date: 2018-05-30 Impact factor: 2.711